Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock
Ocugen(OCGN) Newsfilter·2024-08-03 03:22
MALVERN, Pa., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced the closing of its previously announced underwritten public offering of 30,434,783 shares of its common stock. Each share of common stock was sold at a price to the public of 35 million, before deducting und ...